Evaluation-Therapeutic Industry
EVALUATION THE DRIVER OF CURRENT AND FUTURE MODELS OF THERAPEUTICS DEVELOPMENT Introduction The future of drug development in the pharmaceutical industry heavily relies on therapeutical development, driven by advancement in systems therapeutics and molecular biology. This presents a challenge for the pharmacists to collaborate more with other health professionals or experts, especially biotechnologists, to assist in adapting to the pathology-based era of system therapeutics [1] . The progress in molecular genetics and cell biology determines the primary driving force currently and in the future development of therapeutics. The advancement in technology, such as genome editing technology, has been instrumental in understanding biomolecules that can be exploited to improve drug development and explore therapeutic agents that offer new opportunities in pharmacology [2] . In the background, a socio-cultural environment acts as the driving force to current and future